Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Monster Lawsuits Test State Preemption Of FDA

This article was originally published in The Tan Sheet

Executive Summary

San Francisco City Attorney Dennis Herrera wants Monster to lower its products’ caffeine levels, “provide adequate warning on labels” and “cease targeting minors” in advertising. Monster preemptively sued the city in April, attempting to stop Herrera from pursuing the demands.

You may also be interested in...



Energy Drinks Swayed By Liquid Supplement Draft Guidance After All

Monster Energy products will transition from supplement to conventional food labeling, in a sign that industry may be adapting to FDA’s draft guidance on liquid supplements that stirred controversy upon its publication in 2009.

FDA Supplement Beverage Guidance May Open Can Of Regulatory Worms

An FDA draft guidance has the potential to make defining a beverage as a dietary supplement much tougher

People In Brief

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

Topics

UsernamePublicRestriction

Register

LL033172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel